【ChiCTR2100046077】USING MACHINE LEARNING TO PREDICT KIDNEY INJURY AFTER LOWER LIMB ANGIOPLASTY
ChiCTR2100046077
结束
/
/
/
2021-05-04
/
/
Contrast Associated Acute Kidney Injury
USING MACHINE LEARNING TO PREDICT KIDNEY INJURY AFTER LOWER LIMB ANGIOPLASTY
MACHINE LEARNING PREDICTS CONTRAST INDUCED ACUTE KIDNEY INJURY IN ELECTIVE LOWER LIMB PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY: A RETROSPECTIVE COHORT
169608
Examine risk factors for contrast associated acute kidney injury after elective lower limb percutaneous transluminal angioplasty. Develop machine learning models for risk prediction.
连续入组
回顾性研究
Not applicable as this is a retrospective cohort.
Not applicable as this is a retrospective cohort.
No funding
/
610
/
2020-07-01
2021-07-01
/
- All cases of lower limb PTA as a single procedure identified via surgical codes; - Performed at Singapore General Hospital; - Recruitment period from 2014 to 2020.;
请登录查看- Patients <21 years old; - Patients with a preoperative estimated Glomerular Filtration Rate (eGFR) of <15mL/min/1.73 m2 as defined by the Modification of Diet in Renal Disease (MDRD); - Patients with no valid preoperative or postoperative SCr.;
请登录查看Singapore General Hospital
169608
Singapore General Hospital的其他临床试验
新加坡总医院的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验(FIH)成功开展,国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药:超长效靶向TSLP抗体哮喘二期临床取得阳性结果,三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构:国家药品监督管理局 2026-09-10
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构:国家市场监督管理总局 2026-09-18
-
颁布机构:国家市场监督管理总局 2026-09-17
-
颁布机构:国家市场监督管理总局 2026-08-10
